FR 901483
Alternative Names: WF 11231A . HClLatest Information Update: 05 Jun 2001
At a glance
- Originator Fujisawa
- Class Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 05 Jun 2001 No-Development-Reported for Transplant rejection in Japan (Unknown route)
- 06 Mar 1996 New profile
- 06 Mar 1996 Preclinical development for Transplant rejection in Japan (Unknown route)